What really happens inside the body during high blood pressure

Introduction

Hypertension is often described in simple terms - a number on a screen or a diagnosis made in clinical practice. Yet behind these readings lies a complex network of underlying biological processes. Long before complications arise, subtle changes in the kidneys, blood vessels, and hormonal systems begin to disrupt the body’s ability to regulate blood pressure. Understanding these mechanisms reveals how hypertension develops and why it remains one of the most pressing challenges in modern health. 

Cardiac output and peripheral resistance

Blood pressure is maintained through a balance between cardiac output and peripheral resistance. Cardiac output is the volume of blood pumped per minute, and peripheral resistance is the resistance to blood flow in the peripheral vasculature. In most individuals with hypertension, cardiac output remains relatively normal. Instead, the problem lies with increased resistance in circulation. This resistance is primarily controlled by small blood vessels known as arterioles, which have muscular walls that can constrict or relax to regulate blood flow. Contraction of these muscles is driven partly by increased intracellular calcium, which causes the vessels to narrow and increases resistance. Excess sodium intake further contributes by increasing fluid volume and making blood vessels more likely to constrict (Figure 1).  

Over time, persistent vasoconstriction can lead to structural changes in the vessel walls, causing them to thicken and become less flexible. Hormones such as angiotensin contribute to this process, resulting in a sustained and often irreversible increase in peripheral resistance.

Renin-angiotensin system

One of the most important hormonal systems involved in blood pressure regulation is the renin-angiotensin system. This system is activated when the body senses a drop in blood flow, reduced salt intake, or increased sympathetic activity. In response, the kidneys release renin, an enzyme that converts angiotensinogen to angiotensin I (Figure 2). Angiotensin I is then converted to angiotensin II in the lungs. Angiotensin II plays a central role in raising blood pressure and stimulates the release of the hormone aldosterone from the adrenal gland, which promotes sodium and water retention in the kidneys. Together, these effects increase both vascular resistance and blood volume, leading to a rise in blood pressure. People with high blood pressure do not always have low renin levels. Some have normal renin levels because the kidneys are not strongly activated to change renin release. In contrast, others have high renin levels because reduced blood flow to parts of the kidney stimulates renin release. In some cases, this can be due to underlying kidney or hormonal diseases.  

Autonomic nervous system

The autonomic nervous system (ANS) also plays an important role in regulating blood pressure by controlling how wide or narrow blood vessels are. During stress or physical activity, the sympathetic nervous system (SNS), one division of the autonomic nervous system, is activated, causing the release of noradrenaline and adrenaline. These hormones increase heart rate and cause blood vessels to narrow (vasoconstriction), resulting in an increase in blood pressure. Although this response is important for short-term blood pressure regulation, it is not the main cause of chronic hypertension. However, overactivity of the SNS can contribute to persistently high blood pressure. Their role still remains significant, as drugs that reduce sympathetic activity are effective in lowering blood pressure. For example, adrenergic drugs such as beta-blockers act as sympatholytics by blocking the effects of noradrenaline at adrenergic receptors in the heart and blood vessels, reducing heart rate and how strongly the heart pumps, which decreases blood pressure. This highlights the contribution of the autonomic nervous system to hypertension.

Endothelium dysfunction

The endothelium, the inner lining of the blood vessels, is another key regulator of vascular function. In hypertension, the endothelium becomes dysfunctional, both contributing to and resulting from high blood pressure. Factors such as smoking, diabetes, and high cholesterol can contribute to this process. A key feature of endothelial dysfunction is reduced production of nitric oxide, a molecule that promotes vasodilation. With less nitric oxide available, blood vessels are less able to dilate, which increases resistance and sustains high blood pressure. Oxidative stress further worsens this process by generating reactive oxygen species (ROS) that damage the endothelium and reduce the availability of nitric oxide, creating a cycle that reinforces hypertension. ROS are generated as by-products of mitochondrial metabolism, and their levels increase under conditions of inflammation and metabolic stress. 

Insulin resistance

Insulin resistance is also strongly associated with hypertension. It contributes through several mechanisms, including increased sympathetic activity, sodium retention, and structural changes in blood vessels. Importantly, insulin normally promotes vasodilation, but in individuals with hypertension, this effect is impaired, leading to increased vascular resistance.

Genetic and lifestyle factors

In addition to these physiological mechanisms, genetic and environmental factors play a significant role in the development of hypertension, including lifestyle influences such as diet, physical activity, electrolyte imbalance and obesity. 

Conclusion

Overall, hypertension is a multifactorial condition that arises from the interaction of vascular, renal and hormonal systems, influenced by both genetic predisposition and environmental factors. These interconnected processes create a cycle that sustains and progressively worsens elevated blood pressure over time, highlighting the complexity of its pathophysiology.   

Written by Michelle Amoah

Related articles: Hypertension / Cardiac regeneration

REFERENCES

Adua, E. (2022). Decoding the mechanism of hypertension through multiomics profiling. Journal of Human Hypertension, 37(4), 253–264. 

Beevers, G., Lip, G. Y. H., and O’Brien, E. (2001). The pathophysiology of hypertension. BMJ, 322(7291), 912.1-916.

Hayat, M. A. (2015). Introduction to Autophagy. In Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging (pp. 1–53). Elsevier.

Klabunde, R.E. (2024). Centrally Acting Sympatholytics. CV Pharmacology. Available at: https://cvpharmacology.com/vasodilator/central-acting. Accessed 4th July, 2026. 

Nadar, S. (2015). Pathophysiology of hypertension. In Hypertension (pp. 9–14). Oxford University Press.

Nepali, P., Suresh, S., Pikale, G., Jhaveri, S., Avanthika, C.,Bansal, M., Islam, R., and Chanpura, A. (2022). Hypertension and the Role of Dietary Fiber. Current Problems in Cardiology, 47(7), 101203.  

Sahay, M., and Sahay, R. (2012). Low renin hypertension. Indian Journal of Endocrinology and Metabolism, 16(5), 728.